from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0277c/vapC25

LFCtreatmentdescriptionclass of inhibitor

1.362

Amikacinug/mL Amikacintranslation

2.638

Cap5-10ug/mL Capreomycintranslation

4.341

Rox10-50 ug/mL Roxithromycintranslation

0.446

SM2-5 ug/mL Streptomycintranslation

3.509

Tet5-10 ug/mL Tetracyclinetranslation

0.420

Rif0.2-5ug/mL Rifampicintranscription

0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.537

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.266

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.188

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.579

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.137

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.063

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.392

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.096

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.586

KCN5-20 ug/mL Potassium cyaniderespiration

0.896

NaN30.2-2 mM Sodium aziderespiration

-0.692

Nigericin50 uM Nigericinrespiration

-0.028

TRC10-150 ug/mL Triclosanrespiration

0.270

TRZ10-25 ug/mL Thioridazinerespiration

0.140

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.346

menadione6-10 ug/mL Menadionerespiration

0.145

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.212

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.319

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.591

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.490

NRP_1Non-replicating persistence stage 1dosRassociated

-0.480

Amp0.2mg/mL AmpicillincellWall

0.409

Cephalexin20-100 ug/mL CephalexincellWall

0.084

Cerulenin0.32-5 ug/mL CerulenincellWall

0.029

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.059

EMB10-20 ug/mL EthambutolcellWall

-0.179

Eta12-40 ug/mL EthionamidecellWall

-0.112

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.294

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.968

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.745

BZA0.12 mg/mL BenzamidearomaticAmides

-0.537

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.590

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.019

H2O24 mM hydrogen peroxideDNAdamaging

-0.090

Levo10 ug/mL LevofloxacinDNAdamaging

-0.701

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.356

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.207

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.465

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.156

Antimycin12.5-50 ug/mL Antimycin A?

-0.973

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.243

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.225

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.749

PA8240.2-2 ug/mL PA-824?

0.303

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.391

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.277

Verapamil50 uM Verapamil?

-0.576

mercaptoethanol2 mM 2-Mercaptoethanol?

1.677

methoxatin10-20 ug/mL Methoxatin?